TCM
NTUS

Tributary Capital Management’s Natus Medical Inc NTUS Stock Holding History

Tributary Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-592,536
Closed -$15.6M – 228
2022
Q1 		$15.6M Buy
592,536
+36,130
+6% +$882K 1.23% 36
2021
Q4 		$13.2M Buy
556,406
+113,591
+26% +$2.8M 1% 43
2021
Q3 		$11.1M Buy
442,815
+35,006
+9% +$892K 0.86% 54
2021
Q2 		$10.6M Buy
+407,809
New +$11.1M 0.8% 57

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tributary Capital Management's NTUS Position: Q2 2022 in Review

Tributary Capital Management sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 592,536 shares — an estimated $15.6M sold.

Tributary Capital Management first reported a position in NTUS in Q2 2021 and held it in 4 quarters. The position peaked at $15.6M in Q1 2022. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.

  • Tributary Capital Management reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
  • Tributary Capital Management sold 592,536 Natus Medical Inc shares in Q2 2022, an estimated $15.6M.
  • Tributary Capital Management first reported a position in Natus Medical Inc in Q2 2021 and held it in 4 quarters.
  • Tributary Capital Management's Natus Medical Inc position peaked at $15.6M in Q1 2022.
  • 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.

Based on Tributary Capital Management's 13F filing for Q2 2022, filed 19 Jul 2022.